The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

InMed Pharmaceuticals Struggles With Losses Amid Revenue Decline

TipRanksFeb 14 23:04 ET

InMed Pharmaceuticals Board Reshuffle After Director Resignation

TipRanksFeb 14 15:17 ET

InMed Pharmaceuticals Second Quarter 2025 Earnings: US$3.65 Loss per Share (Vs US$3.71 Loss in 2Q 2024)

Yahoo FinanceFeb 14 06:27 ET

InMed Pharmaceuticals | 8-K: InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

SECFeb 13 09:39 ET · Announcements